Page last updated: 2024-10-31

muscimol and Cancer of Liver

muscimol has been researched along with Cancer of Liver in 2 studies

Muscimol: A neurotoxic isoxazole isolated from species of AMANITA. It is obtained by decarboxylation of IBOTENIC ACID. Muscimol is a potent agonist of GABA-A RECEPTORS and is used mainly as an experimental tool in animal and tissue studies.
muscimol : A member of the class of isoxazoles that is 1,2-oxazol-3(2H)-one substituted by an aminomethyl group at position 5. It has been isolated from mushrooms of the genus Amanita.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bautista, W1
Perez-Alvarez, V1
Burczynski, F1
Raouf, A1
Klonisch, T1
Minuk, G1
Zhang, M1
Gong, Y1
Assy, N1
Minuk, GY1

Other Studies

2 other studies available for muscimol and Cancer of Liver

ArticleYear
Membrane potential differences and GABAA receptor expression in hepatic tumor and non-tumor stem cells.
    Canadian journal of physiology and pharmacology, 2014, Volume: 92, Issue:1

    Topics: AC133 Antigen; Antigens, CD; Cell Line, Tumor; Cell Proliferation; GABA Agonists; Glycoproteins; Hep

2014
Increased GABAergic activity inhibits alpha-fetoprotein mRNA expression and the proliferative activity of the HepG2 human hepatocellular carcinoma cell line.
    Journal of hepatology, 2000, Volume: 32, Issue:1

    Topics: Albumins; alpha-Fetoproteins; Blotting, Northern; Carcinoma, Hepatocellular; Cell Division; Dose-Res

2000